ArticleScientific reports2026
Dose-dependent effects of camel milk on immune function and metabolic health in weaning rats.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breastfeeding cannot fulfill an infant’s nutritional needs beyond six months, necessitating the introduction of alternative milk sources. Camel milk has emerged as a promising candidate due to its rich profile of nutrients and immunomodulatory properties. This study evaluated the dose-dependent effects of camel milk on general health and immune response in post-weaning rats, with particular attention to sex-specific differences. Male and female rats were divided into: control (GI), and four treatment groups receiving 2.4 mL (GII), 3.4 mL (GIII), 4.4 mL (GIV), or 5.4 mL (GV) of camel milk daily for six weeks. Serum biochemical parameters, including lipid profile, liver and kidney function markers, and immunological responses were assessed before and after immunization with sheep red blood cells. While higher doses (4.4–5.4 mL) significantly enhanced immune response and bone health, they concurrently elevated liver and kidney function parameters. The 3.4 mL dose balanced benefits, showing significant immune enhancement and bone health improvement without adverse metabolic effects. These findings demonstrated that camel milk (3.4 mL for rats/473 mL for infants) safely enhanced immune function, while higher doses risk metabolic stress. The results supported camel milk’s potential as a nutritional supplement during weaning but emphasized the importance of dose regulation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.